Core Viewpoint - The company, Shantou Ultrasonic Instrument Research Institute Co., Ltd., specializes in the research, production, and sales of medical imaging and industrial non-destructive testing equipment, with a significant portion of its revenue coming from overseas due to the depreciation of the RMB [3][4]. Company Overview - Shantou Ultrasonic Instrument Research Institute Co., Ltd. was established on November 15, 1982, and went public on January 22, 2025. It is recognized as a national key high-tech enterprise [7]. - The company's main business segments include medical ultrasound (71.16% of revenue), industrial ultrasound (17.30%), accessories (5.72%), X-ray (4.56%), and other (1.26%) [7]. Financial Performance - For the period from January to September 2025, the company reported a revenue of 254 million yuan, a year-on-year decrease of 2.90%, and a net profit attributable to shareholders of 88.94 million yuan, down 3.66% year-on-year [8][9]. - As of September 30, 2025, the company's overseas revenue accounted for 55.26% of total revenue, benefiting from the depreciation of the RMB [3]. Market Activity - On January 15, 2025, the company's stock price fell by 3.56%, with a trading volume of 83.72 million yuan and a turnover rate of 5.99%, resulting in a total market capitalization of 10.207 billion yuan [1]. - The stock has seen a net outflow of 7.16 million yuan from major investors, indicating a reduction in holdings over the past two days [4][5]. Product and Industry Insights - The company showcased its innovative veterinary medical imaging products at the 97th WVC annual conference, engaging with industry experts and gaining valuable user insights [2]. - The industrial ultrasound products are primarily applied in non-destructive testing for water and electricity engineering, including pipelines and pressure vessels [2][3].
超研股份跌3.56%，成交额8371.59万元，近5日主力净流入-422.40万